期刊文献+

细胞质胸苷激酶在乳腺癌中的表达及其临床意义 被引量:3

细胞质胸苷激酶在乳腺癌中的表达及其临床意义
暂未订购
导出
摘要 目的探讨细胞质胸苷激酶(TK1)在乳腺癌组织中的表达情况,并分析其与Ki-67及临床病理因素间的关系。方法应用免疫组化MaxVison法检测70例乳腺癌组织标本中TK1及Ki-67的表达情况,分析二者与乳腺癌各临床病理学参数间的关系。结果 TK1和Ki-67在70例乳腺癌中的表达与患者年龄、组织学分级、淋巴结转移情况及临床分期相关(分别为χ2=13.40,χ2=12.02,χ2=5.71,χ2=20.26,P﹤0.05),但与肿瘤大小无关,且TK1与Ki-67间呈正相关(r=0.888,P<0.01)。结论 TK1表达在不同级别乳腺癌组织中存在差异,分级高者表达高;TK1同Ki67一样是一个灵敏的反应肿瘤细胞增殖的指标。 Objective To investigate the expression of TK 1 and its correlation of TK 1 with Ki-67 and conventional pathological parameters in breast canccr. Methods TK 1 and Ki-67 expressions in 70 cases of breast cancer were detected by immunohistochemical method. The relationship between expression status of two makers and breast cancer's clinic pathological parameters were evaluated. Results Both TK 1 and Ki-67 expression was positively correlated with age, grade, lymph node metastasis and TNM stage, but not with tumor size. There was a significant correlation between the expression ofTK 1 and Ki-67 (r=0.888, P〈0.01).Conclusion The higher histological grade and TNM stage of tumor are, the higher expressions ofTK 1 and Ki-67 are.TK 1 is a sensitive indicator measuring the proliferation ofthmor cells.
出处 《当代医学》 2013年第16期24-26,共3页 Contemporary Medicine
关键词 TK1 Ki-7 乳腺癌 免疫组织化学 TK 1 Ki-67 Breast cancer Immunohistochemistry
  • 相关文献

参考文献9

  • 1Qin He,Yongrong Mao,Jainping Wu. Cytosolic thymidine kinase is a specific histopathologic turnout marker for breast carcinomas[J].lnt J Oncol, 2004,25(4): 945-955.
  • 2Zhang F,Li H,Pendleton AP,et aI.Thymidine kinase ]. irrrnunoassay: a potential marker for breast cancer[J].,Cancer Detect Prey,2001,25(1):8-15.
  • 3He Q, Skog 8,Wang N,et al,Oharacterizatfon of a peptide antibody against a O-terminal part of human and mouse cytosolic thymidine kinase, which is marker for cell proliferation[J].Eur J Cell io1,1996,70(2):117- 124.
  • 4He Q,Zhan6 P,Zou L,et al.Ooncentration of thymidine kinase in serum (S-TK 1) is a more sensitive proliferation marker in human solid tumors %hart its activity[J].Onco/ Pep, 2005,14(4): 1 O13-10 9.
  • 5陈飞宇,唐利立,黄隽.S-TK1在乳腺癌患者新辅助化疗前后检测的意义[J].中国肿瘤临床,2009,36(13):732-735. 被引量:9
  • 6Broei: P,Eomafn S,R, icolleau C-,et al. Thymidine kinase as a proliferatfve marder:Olinical relevance in 1692 primary breast caner patients[J]. Clin Oncol, 2001,19(11 ): 2778-2787.
  • 7陈秀娇,陈建阳,陈智伟,蔡庆发,张鹏飞.TK1在乳腺癌中的表达及与Ki67表达的关系[J].中国医师进修杂志,2010,33(8):5-7. 被引量:9
  • 8陈秀娇,蔡庆发,张鹏飞,郑建盛.TK1蛋白在乳腺浸润性导管癌中的表达及其临床意义[J].中国临床实用医学,2009(8):3-5. 被引量:6
  • 9周道平,王彬,邢晓皖.Ki-67、p53蛋白在乳腺癌组织的表达及临床意义[J].实用肿瘤杂志,2009,24(2):136-139. 被引量:21

二级参考文献32

共引文献37

同被引文献16

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部